Opaleye Management Inc. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 155 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,195,150
-70.8%
1,785,000
-36.5%
0.76%
-76.7%
Q1 2023$10,934,012
+155.3%
2,810,800
+132.9%
3.28%
+119.9%
Q4 2022$4,281,994
+456.1%
1,206,841
+1911.4%
1.49%
+288.8%
Q1 2017$770,000
-44.9%
60,000
+100.0%
0.38%
-68.2%
Q2 2014$1,397,00030,0001.20%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders